Figure 1. Molecular modeling of : a) GES-1 and b) GES-1P174E

Slides:



Advertisements
Similar presentations
TREATMENT FOR SUPERIMPOSED PSEUDOMONAS AERUGINOSA INFECTION.
Advertisements

Game plan Lecture Antibiotics Antibiotic resistance Gene transfer Transformation Transduction Conjugation Lab Lab Exam Pre-lab Transformation.
Emerging Antimicrobial Resistance in Texas The new ESBLs.
2009 CLSI M100-S19 Update Nebraska Public Health Laboratory.
Methods for detection β-lactamases Sarah Alharbi.
Resistance to  -lactam antibiotics within the Enterobacteriaceae Paul D. Fey, Ph. D. University of Nebraska Medical Center.
Dave Warshauer, PhD, D(ABMM)
COL Helen Viscount, PhD, D(ABMM) LTC Steven Mahlen, PhD, D(ABMM)
MDR Organisms in Holy Family Hospital Rawalpindi
Beta lactam antibiotics & Other cell wall synthesis inhibitors
Manufacture of Human Interleukin 13 Protein Using a Prokaryotic Expression System Ryan Rupp, York College of Pennsylvania, Department of Biological Sciences.
PK/PD of Antibiotics in relation to resistance Otto Cars MD Department of Medical Sciences Infectious diseases Uppsala University Sweden.
Aims of study This surveillance study was performed to determine the in vitro activity of ciprofloxacin against clinical isolates of Escherichia coli and.
Secondary Drug Resistance Mutation of TEM-1  -lactamase zAmino acid sequence determinants of  -lactamase structure and activity yJ. Mol. Biol. 258,
Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.
References Summary Background Quality Control Parameters for Omadacycline Minimum Inhibitory Concentration (MIC) Susceptibility Tests Using Fresh Media.
Supplemental testing methods
Dr. Laila M. Matalqah Ph.D. Pharmacology
The Evaluation Of Novel Βeta-Lactam Antibiotics On Clinical Bacterial Isolates. Melvin Grimes 1, Adrienne Murphy 1,Jason Carr 2,and Debra Jackson 1, 1.
REVISED ABSTRACT Background: Omadacycline (OMC) is the first of a new class of tetracyclines, the aminomethylcyclines, and is being developed as a once-daily.
4/28/2017 AST.
MRSA, ESBLs and Carbapenem Resistance
C-158 Genetic and Biochemical Characterisation of OXA-405, a New Extended Spectrum Class D -Lactamase from Serratia marcescens L. Dortet1,2, S. Oueslati1,
Tapasyapreeti Mukhopadhyay, Vrushali Patwardhan, Sarman Singh
Current Status of Antimicrobial Resistance
N°XXXX Rapid detection of extended-spectrum BETA-lactamase producing Enterobacteriaceae from urine using the ESBL NDP test Patrice Nordmann, Laurent Poirel,
Introduction & Purpose Results Conclusions
Afaq R. Afridi, Tanveer Ahmad, Arshad Hussain and Abdul Samad.
The Role of the Microbiology Laboratory in AMS programs
Antimicrobial Spectrum of Activity Visual Learning Exercises (“Flower Diagrams”) This work is licensed under the Creative Commons Attribution-NonCommercial-
Cell wall inhibitor Cephalosporins Dr. Naza M. Ali Lec D
1200 Brussels - Belgium Temocillin is not substrate for OprD2 porin from Pseudomonas aeruginosa H. Chalhoub1,
An Introduction to Medicinal Chemistry 3/e
Enzymes are Proteins with Defined 3D Structures
Clinico-Pathological Conference (CPC) Meet
Cephalosporin and Other Cell Wall Synthesis Inhibitors
Pharmacology of Cephalosporins: General Overview
An In-Depth Look at the GES Family of Enzymes
Antibiotics sensitivity of microorganism causing nosocomial infections
Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli,
Correspondence: Bactericidal Activity of Fosfomycin against NDM-1 producing Enterobacteriaceae M. Albur, A. Noel, K. Bowker, A.
Role of hydrogen bonding in amino acid substitutions of DNA gyrase subunit A-encoding gyrA Cove Soyars.
NDM-1 could still evolve:
RESULTS AND DISCUSSION
Table 1: Resistance profile
Characterisation of the sub-class B2 metallo-β-lactamase
Extended-spectrum beta-lactamases(ESBL)
In the Name of GOD.
Cephalosporin and Cell Wall Synthesis Inhibitors
Gurkan Guntas, Sarah F. Mitchell, Marc Ostermeier  Chemistry & Biology 
Antibiogram By:Dr. S. S. Khoramrooz In the name of God
Finn Werner, Robert O.J Weinzierl  Molecular Cell 
Antibiotic resistance
Difference in kinetic behaviour of catechol 2,3-dioxygenase variants from a polluted environment * 김혜겸 * Howard et al., 2004.
C th Interscience Conference on Antimicrobial Agents and Chemotherapy October 25-28, Washington, DC Examining Temocillin Activity in Combination.
L. Poirel, P. Nordmann  Clinical Microbiology and Infection 
Laura Lancaster, Harry F. Noller  Molecular Cell 
Directed Mutagenesis and Protein Engineering
The Binding of Antibiotics in OmpF Porin
Β-LACTAM ANTIBIOTICS THIENAMYCIN MONOBACTAMS β-LACTAM INHIBITORS.
Cephalosporin and Cell Wall Synthesis Inhibitors
TRAINING PRESENTATION
β- Lactamase Inhibitor
Mechanisms of Resistance and Clinical Relevance of Resistance to β-Lactams, Glycopeptides, and Fluoroquinolones  Louis B. Rice, MD  Mayo Clinic Proceedings 
Carbapenem Resistance: Defining, Detecting, and Responding
2-Methyl-3-Hydroxybutyryl-CoA Dehydrogenase Deficiency Is Caused by Mutations in the HADH2 Gene  Rob Ofman, P.N. Jos Ruiter, Marike Feenstra, Marinus.
Structure, Exchange Determinants, and Family-Wide Rab Specificity of the Tandem Helical Bundle and Vps9 Domains of Rabex-5  Anna Delprato, Eric Merithew,
A Signal Transduction System that Responds to Extracellular Iron
Volume 21, Issue 10, Pages (October 2014)
(A) Comparison of mcr-9 to all previously described mcr homologues, based on amino acid sequence. (A) Comparison of mcr-9 to all previously described mcr.
Presentation transcript:

Figure 1. Molecular modeling of : a) GES-1 and b) GES-1P174E Replacement of proline 174 with glutamic acid in GES-1 enzymes improves the flexibility of -loop leading to an increase of catalytic efficiency towards carbapenems 1Piccirilli A, 1Perilli M, 2Mercuri PS, 3Aschi M, 1Segatore B, 2Galleni M, 1 Celenza G, 1Amicosante G 1 Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, Italy 2 Macromolécules biologiques InBioS-Centre for Protein Engineering, University of Liège, Belgium 3 Dipartimento di Scienze Fisiche e Chimiche, University of L’Aquila, Italy I n t r o d u c t i o n M e t h o d s Figure 1. Molecular modeling of : a) GES-1 and b) GES-1P174E GES-type-enzymes are spreading in several Gram-negative bacteria, including Enterobacteriaceae and nonfermenters strains as Pseudomonas aeruginosa and Acinetobacter baumannii (1,2). To date, twenty-seven GES variants have been discovered, differing from each other by one to three amino acid substitutions (http://lahey.org/studies/). GES-1, the first representative of the GES-family, was found to confer resistance to penicillins, broad spectrum cephalosporins but not to monobactams and carbapenems. Nevertheless, carbapenemase activity has been demonstrated in GES, like GES-2, GES-4, GES-5, GES-6, GES-14, GES-18, GES-20 variants, with a substitution at position 170 were a glycine residue has been replaced by serine or asparagine. a Overlap extension method (3) was used to generate mutants of GES-1 enzyme at position 174. Site-saturation mutagenesis was performed on blaGES-1 gene using degenerated primers. The blaGES-1 and mutated amplicons were inserted into pET-24(a) vector and transferred in Escherichia coli BL21(DE3) for enzymes expression. The recombinant plasmids were selected on LB agar plates supplemented with ampicillin and cefotaxime. The enzymes were extracted from 1,2 L of culture, grown at 37°C until to achieve an A600 of approximately 0.7 OD. At this stage 0.4 mM IPTG (isopropyl-ß-thiogalactoside) was added and the cultures were incubated for 16 h at 22 °C, under aerobic conditions. Purification of the enzymes was made by two chromatographic step: ion-exchange chromatograpgy Sepharose Q and gel filtration Superdex 200. Steady-state kinetic experiments were performed following the hydrolysis of each substrate at 25°C in 20 mM sodium phosphate buffer (pH 7.0). Molecular dynamics (MD) simulations were performed for 100.0 ns on GES-1 and GES-1P174E. P174 E174 b R e s u l t s Figure 2. MD simulations of GES-1 and GES-1P174E complexed with imipenem. The black box highlights the Ω-loop region. Ω-loop Table 1. β-lactams susceptibility of E. coli pET-24/GES-1P174E compared with E. coli pET-24/GES-1 Antibiotics E.coli pET-24 GES-1 E.coli pET-24 GES-1P174E E.coli pET-24 Piperacillin >256 1 Piperacillin + TAZ 256 Amoxicillin 0.5 Imipenem 0.0625 Ertapenem <0.0325 Meropenem 0.25 Cefazolin >128 64 0.125 Cefotaxime 16 2 Ceftazidime <0.0625 Cefepime 8 Cefoxitin Ceftarolin 32 0.0625  Aztreonam In the presence of 4 μg/mL of cefotaxime a GES-1 mutant, where proline (P) at position 174 was replaced by glutamic acid (E), has been selected. The phenotypic profile has been characterized by microdilution method using a bacterial inoculum of 5 x 105 CFU/mL according to Clinical and Laboratory Standards Institute (CLSI) performance standards(4). As shown in Table 1, the GES-1P174E mutant showed higher MIC values towards meropenem, ertapenem and ceftarolin. MD simulations revealed that -Loop is significantly more flexible in the core of GES-1P174E this is in agreement with the observed reduction of Km and an increase of kcat values for carbapenems. Table 2. Kinetic parameters calculated for GES-1 and GES-1P174E C o n c l u s i o n s Substrates GES-1 GES-1P174E   Km (μM) kcat (s-1) kcat/Km (μM-1 s-1) Benzylpenicillin 210±15 117 0.557 187±12 5 0.027 Ampicillin 260±20 236 0.908 230±8 30 0.130 Piperacillin 1400±150 184 0.131 608±25 23 0.038 Carbenicillin 1250±35 41 0.033 3300±65 12 0.0036 Cefazolin 1440±35 375 0.26 143 103 0.72 Meropenem 0.08* 0.007 0.0875 0.1* 0.1 1 Imipenem 0.8* 0.006 0.0075 0.013* 0.01 0.77 Ertapenem 0.25* 0.003 0.012 0.008 0.08 Nitrocefin 325±20 168 0.517 350±20 122 0.348 The proline at position 174 is well conserved in all GES-variants and in more class A carbapenemases. The replacement of proline with glutamic acid changes the flexibility of Ω-loop. In GES-1P174E the -Loop is more flexible and this could explain also the reduction of Km values for carbapenems. R e f e r e n c e s Bebrone C., 2013. Antimicrob. Agents Chemother., 57:396-401. Bogaerts P., 2010. Antimicrob. Agents Chemother., 54:4872-4878. Steffan NH et al. Gene 1989; 77:51-59. CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. Seventh Edition. Document M7-A7, 26 (2). CLSI, Wayne, PA, USA, 2006. Both GES-1 and GES-1P174E were purified at the homogeneity by two chromatographic steps which yielded the enzymes as more than 90% pure, as evaluated by SDS-Page. As shown in table 2, Km, kcat and kcat/Km, were calculated for both enzymes towards several β-lactams. Compared with GES-1, the GES-1P174E showed a significant increase of kcat values and, consequently, of kcat/Km versus carbapenems. The GES-1P174E showed the kcat/Km values for imipenem about 100-fold higher that GES-1.